KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $80.7 billion.

  • Thermo Fisher Scientific's Non-Current Assets rose 541.13% to $80.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $308.2 billion, marking a year-over-year increase of 370.97%. This contributed to the annual value of $75.2 billion for FY2024, which is 141.23% up from last year.
  • Per Thermo Fisher Scientific's latest filing, its Non-Current Assets stood at $80.7 billion for Q3 2025, which was up 541.13% from $76.6 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Non-Current Assets registered a high of $80.7 billion during Q3 2025, and its lowest value of $48.2 billion during Q2 2021.
  • For the 5-year period, Thermo Fisher Scientific's Non-Current Assets averaged around $70.4 billion, with its median value being $74.0 billion (2022).
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 5927.38% in 2021, then crashed by 411.28% in 2022.
  • Over the past 5 years, Thermo Fisher Scientific's Non-Current Assets (Quarter) stood at $75.0 billion in 2021, then fell by 4.11% to $71.9 billion in 2022, then increased by 3.08% to $74.1 billion in 2023, then rose by 1.41% to $75.2 billion in 2024, then increased by 7.37% to $80.7 billion in 2025.
  • Its last three reported values are $80.7 billion in Q3 2025, $76.6 billion for Q2 2025, and $75.7 billion during Q1 2025.